Advanced basal cell carcinoma: What dermatologists need to know about treatment

J Am Acad Dermatol. 2023 Jan;88(1):e63. doi: 10.1016/j.jaad.2022.10.013. Epub 2022 Oct 13.

Authors

Farhaan Hafeez¹, Melissa Wilson², Stephen C Senft¹, Ryan P Johnson¹, Alan Westheim¹, Nadia Abidi¹, Andrew C Krakowski³

Affiliations

¹ St. Luke's Department of Dermatology, St. Luke's University Health Network, Easton, Pennsylvania.
² St. Luke's Cancer Center, St. Luke's University Health Network, Easton, Pennsylvania.
³ St. Luke's Department of Dermatology, St. Luke's University Health Network, Easton, Pennsylvania. Electronic address: Andrew.Krakowski@sluhn.org.

PMID: 36244555
DOI: 10.1016/j.jaad.2022.10.013

No abstract available

Keywords: advanced basal cell carcinoma; cemiplimab; genomics; next-generation sequencing; sonidegib; treatment; vismodegib.

Publication types

Comment

MeSH terms

Anilides / therapeutic use
Antineoplastic Agents* / therapeutic use
Carcinoma, Basal Cell* / drug therapy
Carcinoma, Basal Cell* / therapy
Dermatologists
Hedgehog Proteins
Humans
Skin Neoplasms* / drug therapy
Skin Neoplasms* / therapy

Substances

Antineoplastic Agents
Anilides
Hedgehog Proteins